DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR VENLAFAXINE AND O-DESME THY LVENLA FAXINE: ASSESSING THE IMPACT OF CYP2D6, CYP2C9 AND CYP2C19 GENETIC POLYMORPHISMS

被引：0
|
作者：
Pan, X. [1 ]
Rowland-Yeo, K. [1 ]
机构：
[1] Certara UK, Simcyp Div, Edinburgh, Scotland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-167
引用
收藏
页码：S103 / S104
页数：2
相关论文
共 50 条
  • [1] Effects of polymorphisms in CYP2D6, CYP2C9, and CYP2C19 on trimipramine pharmacokinetics
    Kirchheiner, J
    Müller, G
    Meineke, I
    Wernecke, KD
    Roots, I
    Brockmöller, J
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) : 459 - 466
  • [2] Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms
    Chaudhry, Shafqat Rasul
    Muhammad, Sajjad
    Eidens, Moritz
    Klemm, Marco
    Khan, Dilaware
    Efferth, Thomas
    Weisshaar, Maria-Paz
    CURRENT DRUG METABOLISM, 2014, 15 (07) : 711 - 718
  • [3] Assessment of CYP2C9, CYP2C19, and CYP2D6 Polymorphisms in Allergic Patients with Chemical Sensitivity
    D'Attis, Simona
    Massari, Serafina
    Mazzei, Francesca
    Maio, Dominga
    Vergallo, Ilaria
    Mauro, Salvatore
    Minelli, Mauro
    Bozzetti, Maria Pia
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 179 (03) : 173 - 186
  • [4] Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population
    Bozina, N
    Granic, P
    Lalic, Z
    Tramisak, I
    Lovric, M
    Stavljenic-Rukavina, A
    CROATIAN MEDICAL JOURNAL, 2003, 44 (04) : 425 - 428
  • [5] CYP2D6, CYP2C19 AND CYP2C9 GENOTYPING IN A SWEDISH CLINICAL SETTING
    Scordo, M. G.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E9 - E9
  • [6] Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population
    Jónrit Halling
    Maria S. Petersen
    Per Damkier
    Flemming Nielsen
    Philippe Grandjean
    Pál Weihe
    Stefan Lundgren
    Mia Sandberg Lundblad
    Kim Brøsen
    European Journal of Clinical Pharmacology, 2005, 61 : 491 - 497
  • [7] Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population
    Halling, J
    Petersen, M
    Damkier, P
    Nielsen, F
    Grandjean, P
    Weihe, P
    Lundgren, S
    Lundblad, M
    Brosen, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 491 - 497
  • [8] CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population
    Scott, StuartA
    Edelmann, Lisa
    Kornreich, Rutb
    Erazo, Monica
    Desnick, Robert J.
    PHARMACOGENOMICS, 2007, 8 (07) : 721 - 730
  • [9] Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
    Sistonen, Johanna
    Fuselli, Silvia
    Palo, Jukka U.
    Chauhan, Neelam
    Padh, Harish
    Sajantila, Antti
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (02): : 170 - 179
  • [10] Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans
    Rodrigues-Soares, Fernanda
    Penas-Lledo, Eva M.
    Tarazona-Santos, Eduardo
    Sosa-Macias, Martha
    Teran, Enrique
    Lopez-Lopez, Marisol
    Rodeiro, Idania
    Moya, Graciela E.
    Calzadilla, Luis R.
    Ramirez-Roa, Ronald
    Grazina, Manuela
    Estevez-Carrizo, Francisco E.
    Barrantes, Ramiro
    LLerena, Adrian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 257 - 268
12345